Literature DB >> 7066608

The effect of taurine on high potassium-and noradrenaline-induced contraction in rabbit ear artery.

F Franconi, A Giotti, S Manzini, F Martini, I Stendardi, L Zilletti.   

Abstract

1 Intraluminal administration of taurine (40 mM) did not affect the contractile tone of rabbit isolated ear artery 2 Taurine (10-80 mM) exerted a powerful concentration-dependent, vasodilator action in arteries contracted with high potassium medium. 3 In the same experimental conditions, the taurine analogues beta-alanine and homotaurine, had no effect. 4 Taurine (40-80 mM) did not affect in a significant manner the tonic component of the noradrenaline (5x10(-6 M)-induced contraction. 5 When noradrenaline (5x10(-6M) was followed by the administration of high potassium medium a further increase in intraluminal pressure was observed. Under these conditions taurine (40 mM) reversed specifically the component due to the high potassium medium.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7066608      PMCID: PMC2071529          DOI: 10.1111/j.1476-5381.1982.tb09180.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  26 in total

1.  Excitability modulation by taurine. Transmembrane measurements of neuromuscular transmission.

Authors:  R Gruener; D Markovitz; R Huxtable; R Bressler
Journal:  J Neurol Sci       Date:  1975-03       Impact factor: 3.181

2.  Electromechanical and pharmacomechanical coupling in vascular smooth muscle.

Authors:  A V Somlyo; A P Somlyo
Journal:  J Pharmacol Exp Ther       Date:  1968-01       Impact factor: 4.030

Review 3.  Biochemistry and physiology of taurine and taurine derivatives.

Authors:  J G Jacobsen; L H Smith
Journal:  Physiol Rev       Date:  1968-04       Impact factor: 37.312

4.  The bimodal basis of the contractile response of the rabbit ear artery to norepinephrine and other agonists.

Authors:  J A Bevan; W Garstka; C Su; M O Su
Journal:  Eur J Pharmacol       Date:  1973-04       Impact factor: 4.432

5.  Biphasic vasoconstriction of the rabbit ear artery.

Authors:  O S Steinsland; R F Furchgott; S M Kirpekar
Journal:  Circ Res       Date:  1973-01       Impact factor: 17.367

6.  Antagonism by taurine of cobalt induced epilepsy in cat and mouse.

Authors:  N M Van Gelder
Journal:  Brain Res       Date:  1972-11-27       Impact factor: 3.252

7.  Comparison between ouabain and taurine effects on isolated rat and guinea-pig hearts in low calcium medium.

Authors:  J Dietrich; J Diacono
Journal:  Life Sci I       Date:  1971-05-01

8.  Role of calcium ions in the contraction of vascular smooth muscle.

Authors:  M Hiraoka; S Yamagishi; T Sano
Journal:  Am J Physiol       Date:  1968-05

9.  The separation of cell membrane calcium transport from extracellular calcium exchange in vascular smooth muscle.

Authors:  C Van Breemen; E McNaughton
Journal:  Biochem Biophys Res Commun       Date:  1970-05-22       Impact factor: 3.575

10.  Amino acids in human epileptogenic foci.

Authors:  T L Perry; S Hansen; J Kennedy; J A Wada; G B Thompson
Journal:  Arch Neurol       Date:  1975-11
View more
  5 in total

1.  Role of taurine in the vasculature: an overview of experimental and human studies.

Authors:  Worku Abebe; Mahmood S Mozaffari
Journal:  Am J Cardiovasc Dis       Date:  2011-09-10

Review 2.  Effects of taurine on vascular tone.

Authors:  Oguzhan Yildiz; Kemal Gokhan Ulusoy
Journal:  Amino Acids       Date:  2022-08-19       Impact factor: 3.789

3.  The potential health benefits of taurine in cardiovascular disease.

Authors:  Yan-Jun Xu; Amarjit S Arneja; Paramjit S Tappia; Naranjan S Dhalla
Journal:  Exp Clin Cardiol       Date:  2008

Review 4.  The Effects of Oral Taurine on Resting Blood Pressure in Humans: a Meta-Analysis.

Authors:  Mark Waldron; Stephen David Patterson; Jamie Tallent; Owen Jeffries
Journal:  Curr Hypertens Rep       Date:  2018-07-13       Impact factor: 5.369

5.  Taurine relaxes human radial artery through potassium channel opening action.

Authors:  Kemal Gokhan Ulusoy; Erkan Kaya; Kubilay Karabacak; Melik Seyrek; İbrahim Duvan; Vedat Yildirim; Oguzhan Yildiz
Journal:  Korean J Physiol Pharmacol       Date:  2017-10-30       Impact factor: 2.016

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.